B12 Deficiency Correction: Weekly For confirmed B12 deficiency or pernicious anemia: weekly injections for 48 weeks to saturate body stores, then monthly maintenance
Combining the therapeutic approaches of GLP-1 agonists (which target extrahepatic mechanisms for metabolic disorders) with resmetirom (which target intrahepatic mechanisms for MASH and liver fibrosis) seems like a promising strategy for addressing fat accumulation, inflammation, and fibrosis associated with MASH
Due to its Drug Affinity Complex (DAC) technology, CJC-1295 DAC has been studied more thoroughly in early clinical trials, where it has shown the capacity to raise circulating growth hormone and insulin-like growth factor-1 (IGF-1) levels for extended periods of time
Dose increases should only happen when nausea is mild or has mostly resolved
Based on small-scale results, we develop pilot and scale-up production processes
A larger Novo Nordisk-funded trial found that patients in earlier stages taking semaglutide were more likely than those on a placebo to see their NASH resolved, but not significantly more likely to see their scarring improve